Watson David O. - 28 Jan 2026 Form 4 Insider Report for Apellis Pharmaceuticals, Inc. (APLS)

Role
General Counsel
Signature
David Watson
Issuer symbol
APLS
Transactions as of
28 Jan 2026
Net transactions value
$0
Form type
4
Filing time
30 Jan 2026, 16:06:43 UTC
Previous filing
23 Jan 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Watson David O. General Counsel C/O APELLIS PHARMACEUTICALS, INC, 100 FIFTH AVENUE, 3RD FLOOR, WALTHAM David Watson 30 Jan 2026 0001657719

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction APLS Common Stock Award $0 +55,986 +63% $0.000000 144,517 28 Jan 2026 Direct F1
holding APLS Common Stock 10,000 28 Jan 2026 Indirect Owner (Custodial Account for minor children) F2
holding APLS Common Stock 50,136 28 Jan 2026 Indirect Owner (The David O. Watson Irrevocable Trust of 2023) F3
holding APLS Common Stock 0 28 Jan 2026 Indirect Owner (The Watson Education Trust) F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This represents a Restricted Stock Unit award granted on January 28, 2026 that vest 25% annually over four years from grant date subject to continued service.
F2 This represents a custodial account held by the reporting person for the sole benefit of his minor children.
F3 The securities are held by The David O. Watson Irrevocable Trust of 2023. William Zorn is the trustee of The David O. Watson Irrevocable Trust of 2023. The reporting person disclaims beneficial ownership over the shares held by The David O. Watson Irrevocable Trust of 2023 except to the extent of his pecuniary interest therein.
F4 The securities are held by The Watson Education Trust (the "Trust"), for which the reporting person serves as trustee. The reporting person disclaims beneficial ownership over the shares held by the Trust except to the extent of his pecuniary interest therein.